Nvidia: AI Leader Trading at an Attractive Valuation
July 1, 2025 Where to Rent Stable Turkish Datacenter Proxies?
June 24, 2025 PayPal’s News Analysis—A Short and Medium-Term Price Forecast
June 10, 2025 Understanding Accounting and Bookkeeping Services for Business Success
May 27, 2025 How much does a Turkish passport cost?
May 22, 2025 How Measurement and Mix Modeling Drive Better Business Decisions
Ocuphire Pharma (OCUP) Stock Forecast for 2025, 2026, 2027. Sell or Buy?
Updated: July 9, 2025 (07:37)
Sector: HealthcareThe share price of Ocuphire Pharma, Inc. (OCUP) now
Are you interested in Ocuphire Pharma, Inc. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Ocuphire Pharma stock price in 2025, 2026, 2027. How much will one Ocuphire Pharma share be worth in 2025 - 2027?
When should I take profit in Ocuphire Pharma stock? When should I record a loss on Ocuphire Pharma stock? What are analysts' forecasts for Ocuphire Pharma stock? What is the future of Ocuphire Pharma stock? We forecast Ocuphire Pharma stock performance using neural networks based on historical data on Ocuphire Pharma stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.
Ocuphire Pharma stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals. (Next month, 2025, 2026, 2027, and ) The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for Ocuphire Pharma shares. This happens once a day.
Historical and forecast chart of Ocuphire Pharma stock
The chart below shows the historical price of Ocuphire Pharma stock and a prediction chart for the next month.
For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast,
and Weighted Average Best Forecast. Detailed values for the Ocuphire Pharma stock price can be found in the table below.
Long-term forecasts by years.
Ocuphire Pharma, Inc. engages in the research and development of ophthalmic biopharmaceutical products. It focuses on developing and commercializing therapies for the treatment of several eye disorders. The company was founded by Mina Patel Soouch and Alan R. Meyer in February 2018 and is headquartered in Farmington Hills, MI.
Ocuphire Pharma daily forecast for a month
| Date | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jul 11 | 1.19 | 1.16 | 1.20 | 3.33 |
| Jul 12 | 1.20 | 1.18 | 1.21 | 2.13 |
| Jul 13 | 1.17 | 1.15 | 1.19 | 3.98 |
| Jul 14 | 1.15 | 1.13 | 1.16 | 2.16 |
| Jul 15 | 1.15 | 1.14 | 1.17 | 3.27 |
| Jul 16 | 1.16 | 1.14 | 1.18 | 3.38 |
| Jul 17 | 1.16 | 1.15 | 1.17 | 2.11 |
| Jul 18 | 1.14 | 1.12 | 1.16 | 3.66 |
| Jul 19 | 1.15 | 1.12 | 1.16 | 3.34 |
| Jul 20 | 1.14 | 1.12 | 1.16 | 3.95 |
| Jul 21 | 1.15 | 1.12 | 1.17 | 4.24 |
| Jul 22 | 1.14 | 1.13 | 1.17 | 3.33 |
| Jul 23 | 1.14 | 1.12 | 1.16 | 3.92 |
| Jul 24 | 1.13 | 1.11 | 1.14 | 2.98 |
| Jul 25 | 1.16 | 1.15 | 1.19 | 3.21 |
| Jul 26 | 1.16 | 1.14 | 1.18 | 4.01 |
| Jul 27 | 1.15 | 1.14 | 1.16 | 2.09 |
| Jul 28 | 1.13 | 1.11 | 1.14 | 3.59 |
| Jul 29 | 1.12 | 1.09 | 1.13 | 3.19 |
| Jul 30 | 1.13 | 1.11 | 1.15 | 3.27 |
| Jul 31 | 1.14 | 1.13 | 1.15 | 2.21 |
| Aug 01 | 1.15 | 1.12 | 1.17 | 3.95 |
| Aug 02 | 1.17 | 1.16 | 1.18 | 2.43 |
| Aug 03 | 1.18 | 1.17 | 1.21 | 3.62 |
| Aug 04 | 1.17 | 1.16 | 1.18 | 1.66 |
| Aug 05 | 1.18 | 1.16 | 1.20 | 3.35 |
| Aug 06 | 1.18 | 1.16 | 1.21 | 4.48 |
| Aug 07 | 1.19 | 1.17 | 1.21 | 3.13 |
| Aug 08 | 1.19 | 1.16 | 1.21 | 4.24 |
| Aug 09 | 1.20 | 1.19 | 1.22 | 2.72 |
Ocuphire Pharma Daily Price Targets
Ocuphire Pharma Stock Forecast 07-11-2025.
Forecast target price for 07-11-2025: $1.19.
Positive dynamics for Ocuphire Pharma shares will prevail with possible volatility of 3.222%.
Pessimistic target level: 1.16
Optimistic target level: 1.20
Ocuphire Pharma Stock Forecast 07-12-2025.
Forecast target price for 07-12-2025: $1.20.
Positive dynamics for Ocuphire Pharma shares will prevail with possible volatility of 2.082%.
Pessimistic target level: 1.18
Optimistic target level: 1.21
Ocuphire Pharma Stock Forecast 07-13-2025.
Forecast target price for 07-13-2025: $1.17.
Negative dynamics for Ocuphire Pharma shares will prevail with possible volatility of 3.824%.
Pessimistic target level: 1.15
Optimistic target level: 1.19
Ocuphire Pharma Stock Forecast 07-14-2025.
Forecast target price for 07-14-2025: $1.15.
Negative dynamics for Ocuphire Pharma shares will prevail with possible volatility of 2.113%.
Pessimistic target level: 1.13
Optimistic target level: 1.16
Ocuphire Pharma Stock Forecast 07-15-2025.
Forecast target price for 07-15-2025: $1.15.
Positive dynamics for Ocuphire Pharma shares will prevail with possible volatility of 3.166%.
Pessimistic target level: 1.14
Optimistic target level: 1.17
Ocuphire Pharma Stock Forecast 07-16-2025.
Forecast target price for 07-16-2025: $1.16.
Positive dynamics for Ocuphire Pharma shares will prevail with possible volatility of 3.265%.
Pessimistic target level: 1.14
Optimistic target level: 1.18
OCUP (OCUP) Monthly Stock Prediction for 2025
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jul. | 1.26 | 1.14 | 1.31 | 12.68 |
| Aug. | 1.26 | 1.14 | 1.37 | 16.88 |
| Sep. | 1.22 | 1.13 | 1.33 | 14.86 |
| Oct. | 1.21 | 1.10 | 1.33 | 16.82 |
| Nov. | 1.23 | 1.14 | 1.35 | 15.30 |
| Dec. | 1.33 | 1.22 | 1.42 | 13.76 |
Ocuphire Pharma forecast for this year
Ocuphire Pharma Stock Prediction for Jul 2025
An uptrend is forecast for this month with an optimal target price of $1.26126. Pessimistic: $1.14. Optimistic: $1.31
Ocuphire Pharma Stock Prediction for Aug 2025
An downtrend is forecast for this month with an optimal target price of $1.25798. Pessimistic: $1.14. Optimistic: $1.37
Ocuphire Pharma Stock Prediction for Sep 2025
An downtrend is forecast for this month with an optimal target price of $1.22364. Pessimistic: $1.13. Optimistic: $1.33
Ocuphire Pharma Stock Prediction for Oct 2025
An downtrend is forecast for this month with an optimal target price of $1.20932. Pessimistic: $1.10. Optimistic: $1.33
Ocuphire Pharma Stock Prediction for Nov 2025
An uptrend is forecast for this month with an optimal target price of $1.23133. Pessimistic: $1.14. Optimistic: $1.35
Ocuphire Pharma Stock Prediction for Dec 2025
An uptrend is forecast for this month with an optimal target price of $1.32737. Pessimistic: $1.22. Optimistic: $1.42
Ocuphire Pharma (OCUP) Monthly Stock Prediction for 2026
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jan | 1.24 | 1.12 | 1.33 | 15.84 |
| Feb | 1.22 | 1.19 | 1.26 | 6.30 |
| Mar | 1.21 | 1.12 | 1.29 | 13.65 |
| Apr | 1.21 | 1.13 | 1.26 | 10.71 |
| May | 1.23 | 1.18 | 1.30 | 9.12 |
| Jun | 1.13 | 1.01 | 1.19 | 15.35 |
| Jul | 1.07 | 1.00 | 1.14 | 12.44 |
| Aug | 1.05 | 0.98 | 1.09 | 10.31 |
| Sep | 1.12 | 1.04 | 1.17 | 11.22 |
| Oct | 1.17 | 1.14 | 1.21 | 6.41 |
| Nov | 1.25 | 1.21 | 1.31 | 7.42 |
| Dec | 1.34 | 1.30 | 1.46 | 10.84 |
Ocuphire Pharma (OCUP) Monthly Stock Prediction for 2027
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jan | 1.35 | 1.26 | 1.47 | 14.20 |
| Feb | 1.19 | 1.15 | 1.31 | 12.61 |
| Mar | 1.09 | 1.00 | 1.19 | 15.79 |
| Apr | 1.11 | 1.03 | 1.18 | 13.15 |
| May | 1.04 | 0.93 | 1.13 | 17.73 |
| Jun | 1.02 | 0.94 | 1.06 | 11.09 |
| Jul | 1.14 | 1.06 | 1.25 | 14.92 |
| Aug | 1.15 | 1.05 | 1.25 | 16.09 |
| Sep | 1.21 | 1.11 | 1.33 | 16.58 |
| Oct | 1.09 | 1.02 | 1.13 | 10.29 |
| Nov | 1.04 | 0.99 | 1.13 | 12.47 |
| Dec | 1.04 | 0.99 | 1.07 | 7.42 |
Ocuphire Pharma information and performance
N/A
Market capitalization of the Ocuphire Pharma, Inc. is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of OCUP shares in the company outstanding by the market price of one share.
EBITDA of Ocuphire Pharma is earnings before interest, income tax and depreciation of assets.
P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit
Price/earnings to growth
Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.
Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.
EPS shows how much of the net profit is accounted for by the common share.
Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.
Forward P/E uses projections of future earnings instead of final numbers.
Enterprise Value (EV) /Revenue
The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).
Number of issued ordinary shares
Number of freely tradable shares
Shares Short Prior Month - the number of shares in short positions in the last month.
FAQ (Frequently Asked Questions about Ocuphire Pharma Stock)
Should I Buy Ocuphire Pharma Shares in 2025 year?
Does Ocuphire Pharma pay dividends?
Which economic sector do Ocuphire Pharma's shares belong to?
Which other securities belong to the same sector as Ocuphire Pharma's shares?
